Kodiak Sciences Inc.

Stocks

KOD

US50015M1099

Market Closed - Nasdaq 16:00:00 2026-10-30 EDT			5-day change	1st Jan Change
99.18 ^USD	-1.22%		+13.18%	+254.72%

10-07	Kodiak Sciences Inc. Presents Clinical Data Across All Three Late-Stage Programs At AAO 2026	CI
10-06	Kodiak Sciences Stock Pick of the Week at Smart Insider Following Insider Share Purchase	MT

Transcript : Kodiak Sciences Inc. - Special Call

Published on 09/28/2026 at 10:21 am EDT - Modified on 09/28/2026 at 01:36 pm EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Thank you for standing by, and welcome to Kodiak Sciences DAYBREAK webcast. [Operator Instructions] Please be advised that today's conference is being

This article is reserved for our subscribers.

Subcribe
to read the article

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about Kodiak Sciences Inc.

10-07	Kodiak Sciences Inc. Presents Clinical Data Across All Three Late-Stage Programs At AAO 2026	CI
10-06	Kodiak Sciences Stock Pick of the Week at Smart Insider Following Insider Share Purchase	MT
09-28	US Equity Indexes Fall as Iran Talks Stall, Fed Governor Points to Higher Rates, Inflation	MT
09-28	Kodiak Shares Soar After Eye Drug Candidates Meet Primary Endpoints in Late-Stage Trial	MT
09-28	US Equity Indexes Fall as Iran Settlement Talks Lose Momentum	MT
09-28	Top Midday Gainers	MT
09-28	Top Midday Stories: MongoDB CEO Leaves to Lead Meta Enterprise Platform; Nvidia Ups Buyback Program by $150 Billion	MT
09-28	Kodiak Sciences Inc. - Special Call
09-28	Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as Oil Prices Rise	MT
09-28	Kodiak Sciences Inc. Announces Zenkuda and Tabirafusp-Ted Meet Primary Endpoints in Phase 3 Daybreak Study in Patients with Wet Age-Related Macular Degeneration	CI
09-28	Top Premarket Gainers	MT
09-28	Kodiak's Eye Drug Candidates Meet Primary Endpoints in Late-Stage Trial, Shares Rise	MT
09-24	Kodiak Sciences Upcoming Data Could Support Upside, UBS Says	MT
08-13	Kodiak Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-10	Kodiak Sciences Says First Patients Enrolled in Late-Stage Diabetic Eye Disease Trial	MT